Didier Surdez

Didier Surdez is currently working as an Assistant Professor at the University of Zurich, where they are exploring synthetic lethal mechanisms in bone sarcoma for potential therapeutic opportunities. Previously, they worked as a Senior Scientist at Institut Curie, focusing on deciphering the genomic landscape of Ewing sarcoma. As a Post-Doc, they conducted research on Ewing sarcoma targeted therapies and cancer mouse models. Didier also holds a Doctor of Pharmacy degree from the University of Basel and a Doctor of Philosophy degree in Neuroscience from EPFL.